Armune closes $5M series A round

Diagnostics company Armune Bioscience Inc. (Kalamazoo, Mich.) closed its series A round at $5 million with the addition of investments from Grand Angels Venture Fund and the University of Michigan's Michigan Investment in New Technology Start-ups (MINTS) program. In March, it had announced a $4 million first close without naming its investors.

The company is retaining Mavericks Capital to raise a planned $25 million series B round. ...